94 related articles for article (PubMed ID: 1331233)
1. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected].
Wong GH; Tartaglia LA; Lee MS; Goeddel DV
J Immunol; 1992 Nov; 149(10):3350-3. PubMed ID: 1331233
[TBL] [Abstract][Full Text] [Related]
2. The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity.
Lidbury BA; Rathjen DA; Ramshaw IA; Cowden WB
Biotechnol Ther; 1994; 5(1-2):27-45. PubMed ID: 7703831
[TBL] [Abstract][Full Text] [Related]
3. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
[TBL] [Abstract][Full Text] [Related]
4. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.
Tartaglia LA; Goeddel DV; Reynolds C; Figari IS; Weber RF; Fendly BM; Palladino MA
J Immunol; 1993 Nov; 151(9):4637-41. PubMed ID: 8409424
[TBL] [Abstract][Full Text] [Related]
6. The enhancement of human tumor necrosis factor-alpha antiviral activity in vivo by monoclonal and specific polyclonal antibodies.
Lidbury BA; Aston R; Ramshaw IA; Cowden WB; Rathjen DA
Lymphokine Cytokine Res; 1993 Apr; 12(2):69-74. PubMed ID: 8324079
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
Kost ER; Mutch DG; Herzog TJ
Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
[TBL] [Abstract][Full Text] [Related]
8. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
Lidbury BA; Ramshaw IA; Sambhi SK
Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
[TBL] [Abstract][Full Text] [Related]
9. Antiviral effects of recombinant human tumor necrosis factor.
Ito M; O'Malley JA
Lymphokine Res; 1987; 6(4):309-18. PubMed ID: 2448553
[TBL] [Abstract][Full Text] [Related]
10. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody.
Corti A; Bagnasco L; Cassani G
Lymphokine Cytokine Res; 1994 Jun; 13(3):183-90. PubMed ID: 7524695
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression.
Jacobsen FW; Dubois CM; Rusten LS; Veiby OP; Jacobsen SE
J Immunol; 1995 Apr; 154(8):3732-41. PubMed ID: 7535812
[TBL] [Abstract][Full Text] [Related]
12. The antiviral activity of tumor necrosis factor in HeLa cells is not mediated by interferons. Studies with TNF-resistant variants.
Gessani S; Johnson SE; McCandless S; Baglioni C
J Biol Regul Homeost Agents; 1988; 2(3):139-44. PubMed ID: 2474237
[TBL] [Abstract][Full Text] [Related]
13. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
[TBL] [Abstract][Full Text] [Related]
14. Roles of two tumor necrosis factor receptors in induction of differentiation of ML-1 cells.
Takeda K; Iwamoto S; Takeda M
Anticancer Res; 1993; 13(4):883-6. PubMed ID: 8394678
[TBL] [Abstract][Full Text] [Related]
15. Increase of MnSOD expression and decrease of JNK activity determine the TNF sensitivity in bcl2-transfected L929 cells.
Kim YH; Kim SS
Cytokine; 1999 Apr; 11(4):274-81. PubMed ID: 10328866
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
Tsujimoto M; Yip YK; Vilcek J
J Immunol; 1986 Apr; 136(7):2441-4. PubMed ID: 3005410
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W
Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of tumor necrosis factor receptors 1 and 2 of the goldfish (Carassius aurutus L.).
Grayfer L; Belosevic M
Mol Immunol; 2009 Jul; 46(11-12):2190-9. PubMed ID: 19446337
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.
Sedger LM; Shows DM; Blanton RA; Peschon JJ; Goodwin RG; Cosman D; Wiley SR
J Immunol; 1999 Jul; 163(2):920-6. PubMed ID: 10395688
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
Dunne SL; Bajzer Z; Vuk-Pavlović S
Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]